| Q2 2024 |
57 |
$195M |
+$4.49M |
-$41.8M |
-$37.3M |
CVII, SLAM, TRTL, PEGR, BITE
|
13F-HR |
8/14/2024, 08:00 AM |
| Q1 2024 |
63 |
$228M |
+$8.35M |
-$111M |
-$103M |
CVII, SLAM, TRTL, SCRM, PEGR
|
13F-HR |
5/15/2024, 01:28 PM |
| Q4 2023 |
79 |
$367M |
+$23M |
-$146M |
-$123M |
CVII, HCVI, GHIX, EMLD, SLAM
|
13F-HR |
2/13/2024, 10:46 AM |
| Q3 2023 |
136 |
$487M |
+$113M |
-$176M |
-$63.3M |
CVII, HCVI, HYG, GHIX, EMLD
|
13F-HR |
11/14/2023, 08:11 AM |
| Q2 2023 |
163 |
$549M |
+$74M |
-$198M |
-$124M |
CVII, HYG, IWM, GHIX, CCVI
|
13F-HR |
8/14/2023, 09:06 AM |
| Q1 2023 |
143 |
$664M |
+$279M |
-$33.8M |
+$245M |
CVII, HYG, IWM, GHIX, LITT
|
13F-HR |
5/15/2023, 08:36 AM |
| Q4 2022 |
183 |
$621M |
|
|
|
CVII, TWLV, HYG, GHIX, LITT
|
13F-HR |
2/14/2023, 07:13 AM |